2-(4-(2-(TRIFLUOROMETHYL)PHENYL)PIPERIDINE-1-CARBOXAMIDO)BENZOIC ACID, 95%, 250mg

1-(3-Fluorophenyl)-2-methylsulfonylethanone, 95.0%, 1g

6-BOC-2-HYDROXY-6-AZASPIRO[3.5]NONANE, 95.0%, 500mg

4-Hydroxy-4'-nitrostilbene, 5g

Sarpogrelate hydrochloride, 98%, 25g

3-Cyclohexylprop-2-ynoic acid, 97%, 1g

2-(Chloromethyl)quinoxaline, 98%, 5g

Símbolo de advertencia según ISO 7010 Etiqueta individual, Sustancias inflamables, Longitud lateral 100 mm, 1 pieza

Methyl 3-bromo-2-fluorobenzoate, 97.0%, 25g

5-Bromo-N-(2,2-dimethoxyethyl)pyrimidin-2-amine, 95.0%, 5g

6-Fluoro-8-isocyanato-4H-benzo[1,3]dioxine, 95.0%, 5g

(E)-N-(4-((E)-3,5-Dimethoxystyryl)phenyl)-3-(3,4,5-trimethoxyphenyl)acrylamide, 98%, 25mg

4-Methoxy-3-(quinolin-8-yloxymethyl)benzaldehyde, 5g